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Abstract Chalcone synthase (CHS) and stilbene synthase
(STS) are related plant polyketide synthases belonging to the
CHS superfamily. CHS and STS catalyze common condensation
reactions of p-coumaroyl-CoA and three C2-units from malonyl-
CoA but different cyclization reactions to produce naringenin
chalcone and resveratrol, respectively. Using purified Pueraria
lobata CHS and Arachis hypogaea STS overexpressed in
Escherichia coli, bisnoryangonin (BNY, the derailed lactone
after two condensations) and p-coumaroyltriacetic acid lactone
(the derailed lactone after three condensations) were detected
from the reaction products. More importantly, we found a cross-
reaction between CHS and STS, i.e. resveratrol production by
CHS (2.7^4.2% of naringenin) and naringenin production by
STS (1.4^2.3% of resveratrol), possibly due to the conforma-
tional flexibility of their active sites.
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1. Introduction
Chalcone synthase (CHS, E.C. 2.3.1.74) catalyzes the ¢rst
reaction of £avonoid biosynthesis and stilbene synthase (STS,
E.C. 2.3.1.95) catalyzes biosynthesis of stilbene backbone of
stilbene-type phytoalexins. CHS and STS are similar both in
mechanistic and structural aspects and are representative
members of the CHS superfamily [1]. CHS and STS are ho-
modimers of identical subunits of 43 kDa and catalyze repet-
itive decarboxylative condensation of a p-coumaroyl residue
with three C2-units from malonyl-CoA. Although both en-
zymes share common starting materials with identical stoichi-
ometry and apparently use the same condensation mechanism
up to the common tetraketide intermediate, CHS and STS
catalyze di¡erent ring closure reactions involving di¡erent
atoms to give rise to di¡erent products, naringenin chalcone
and resveratrol, respectively (Fig. 1). The amino acid homol-
ogy between these two enzymes is more than 65%, and a
phylogenetic analysis showed a higher homology between
CHS and STS from related plants than among CHSs and
STSs, suggesting that STSs have evolved from CHSs several
times independently [2].
It has been demonstrated that, under certain in vitro con-
ditions, CHS produces not only naringenin chalcone but also
triacetic acid lactone (TAL) and styrylpyrone as early release
(derailment) byproducts [3,4]. TAL was also detected from the
reaction products by fatty acid synthase [5] and certain poly-
ketide synthases [6,7]. On the other hand, such derailment
products have not been observed in the reaction catalyzed
by STS [8].
Using puri¢ed Pueraria lobata (kudzu) CHS and Arachis
hypogaea (peanut) STS that was overexpressed in Escherichia
coli, we have detected bisnoryangonin (BNY, the derailed
lactone after two condensations) and p-coumaroyltriacetic
acid lactone (CTAL, the derailed lactone after three conden-
sations) from the reaction products produced by either CHS
or STS. Furthermore, we found a cross-reaction between CHS
and STS, i.e. resveratrol production by CHS and naringenin
production by STS in small but detectable amounts.
2. Materials and methods
2.1. Cloning
Transcription of STS was induced by cutting peanut seedlings (Sa-
kata, Japan) into slices (1 mm thick) that had been immersed in water
for 3 days [9]. The slices were then left overnight in water at 25‡C in
darkness. Total RNA was prepared by the phenol method. cDNA was
synthesized using an oligo dT-XbaI primer (5P-GTC GAC TCT AGA
(T)15-3P) and PCR-ampli¢ed with primers designed from the published
A. hypogaea STS sequence [10]; the forward primer (5P-CAT CCA
TGG TGT CTG TGA GTG AAT TC-3P) and the reverse primer
(5P-GTA TTA TAT GGC CAT GCT GCG GAG-3P). The forward
primer carries an NcoI site suitable for cloning into the expression
vector, pET-3d. The resulting PCR product was ¢rst blunt-ligated
into the SmaI site of pBluescriptIISK(+) (MBI Fermentas), rescued
by NcoI/BamHI digestion, and ligated into the NcoI/BamHI restricted
vector pET-3d to give pET-3d/STS. The NcoI digestion was carried
out in the presence of EtBr (40 Wg/ml) to obtain the 1.2-kb full-length
cDNA because of the presence of another NcoI site in the coding
region. DNA sequencing was carried out on both strands with several
forward and reverse primers using the Dye Terminator Cycle Se-
quencing kit from Applied Biosystems (CA, USA).
Construction of pET-3d/CHS using similar methods has been de-
scribed [11].
2.2. Protein expression and puri¢cation
E. coli BL21(DE3)pLysE cells transformed with either pET-3d/CHS
or pET-3d/STS were grown at 37‡C in LB medium containing 50 Wg/
ml ampicillin and 25 Wg/ml chloramphenicol and induced with 0.4 mM
IPTG. After an induction period of 4 h at 37‡C, the cells were har-
vested, washed and suspended in bu¡er A (10 mM potassium phos-
phate (KPi) bu¡er (pH 7.5), 2 mM DTT). Following sonication (10 s
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U10) on ice and centrifugation (12 000Ug, 4‡C, 15 min), soluble
fractions were obtained. After (NH4)2SO4 precipitation (30^80% sat-
uration), CHS was puri¢ed to apparent homogeneity by successive
chromatography procedures: (1) DEAE-Toyopearl (TOSOH, Tokyo,
Japan) anion exchange chromatography using a linear gradient of
NaCl (0^500 mM) in bu¡er A, (2) Bio-Gel hydroxyapatite (Bio-
Rad) using a linear gradient of 10^300 mM KPi (pH 7.5) containing
2 mM DTT and (3) chromatofocusing on polybu¡er exchanger
(PBE94, Pharmacia) pre-equilibrated with 25 mM imidazole-HCl
(pH 7.4), 2 mM DTT and eluted with Polybu¡er74-HCl (pH 5.0),
2 mM DTT. STS was similarly puri¢ed after successive DEAE ion
exchange and hydroapatite chromatography steps. Protein contents
were determined with Bradford’s dye method (Bio-Rad) [12], using
bovine serum albumin as standard.
Expression and puri¢cation of P. lobata CHS and A. hypogaea STS
as thioredoxin-HisTag fusion proteins (Trx-CHS and Trx-STS) used
in the LC-MS analysis of cross-reaction will be described elsewhere.
2.3. Enzyme assay
For both CHS and STS, the reaction mixture (0.1 ml) contained
appropriate amounts of protein (2^5 Wg of puri¢ed enzyme), 0.1 mM
p-coumaroyl-CoA and 16.8 WM [2-14C]malonyl-CoA (2.2 GBq/mmol,
NEN) in 0.1 M KPi bu¡er (pH 7.5) (K2HPO4/KH2PO4) containing
2 mM DTT. After incubation at 37‡C for 30 min, 50 Wl of 50% acetic
acid was added and the reaction products were extracted with 200 Wl
of ethyl acetate. A portion (50 Wl) of the extract was analyzed by TLC
on RP18 plate (Merck) with methanol:H2O:acetic acid (60:40:1) as
solvent and the radioactive products were quanti¢ed with an Imaging
Plate analyzer (BAS2000, Fuji). Authentic compounds, TAL
(Rf = 0.65, Tokyo Kasei), resveratrol (Rf = 0.50, Sigma) and naringe-
nin (Rf = 0.32, Nacalai tesque) were used as internal standards to
identify the products. The speci¢c enzyme activity was expressed in
pmol of the product produced/s/mg (pkat/mg).
2.4. Identi¢cation of bisnoryangonin and p-coumaroyltriacetic acid
lactone
For identi¢cation of BNY, the ethyl acetate-extracted products
produced by STS and CHS were ¢rst separated by HPLC. The col-
umn (5 Wm, 4.6 mm I.D. U150 mm, ODS80Ts, TOSOH) was washed
at a £ow rate of 0.6 ml/min at 40‡C with 45% methanol in H2O
containing 1% acetic acid for 10 min and then the concentration of
methanol was increased to 55% during the next 30 min. Detection was
with an UV monitor at 254 nm. The peak at Rt = 16.3 min was
collected and, after evaporation of the solvent, the residues were dis-
solved in methanol and reacted with trimethylsilyldiazomethane in the
dark for 30 min at 22‡C. The resulting sample was subjected to GC-
MS (Hewlett Packard 5890 coupled with JEOL JMS-SX102A) anal-
ysis using a DB5 column (0.25 mm I.D. U30 m, ¢lm thickness 0.25
Wm, J and W) at 200‡C to 250‡C (10‡C/min). The retention time and
mass spectrum were found to be identical to those of authentic yan-
gonin: GC, Rt = 22 min; EIMS (70 eV, m/z), 258 (M), 230, 187.
Production of CTAL by CHS and STS was con¢rmed by LC-MS
(see below). CTAL: Multi-stage LC-APCIMS, MS m/z 273.1
[M+H], 271.1 [M3H]3, MS/MS (precursor ion of m/z 271.1) 227.2
[M3H3CO2]3, MS/MS/MS (transitions m/z 271.1s 227.2) 185.2
[M3H3CO23CH2CO]3.
2.5. Cross-reaction
The enzyme reaction was carried out under the same conditions as
described above except that the reaction volume was 1 ml and about
50 Wg of enzyme (10^40 pkat/mg) was used. Radioactive products thus
obtained were redissolved in 500 Wl of 50% aqueous methanol con-
taining 1% acetic acid in which authentic resveratrol (1.5 Wg) and
naringenin (2 Wg) were added. Using a Hitachi 655 HPLC system
and ODS-80Ts column (TOSOH), the radioactive products were sep-
arated with isocratic elution with 50% aqueous methanol containing
1% acetic acid for 30 min. Radioactivity of each 0.5 ml fraction was
measured with a L-scintillation counter and the fractions correspond-
ing to main product (naringenin for CHS and resveratrol for STS)
and cross-reaction product (resveratrol for CHS and naringenin for
STS) were collected. For carrier dilution analysis, recrystallization of
the radioactive products with carrier compounds was performed at
least four times in two di¡erent solvent systems (methanol and ethyl
acetate/hexane) and speci¢c radioactivity was measured after each
recrystallization step.
The identity of the cross-reaction products was further con¢rmed
by GC-MS and LC-MS. First, the CHS and STS reaction products
were methylated with trimethylsilyldiazomethane and analyzed by
GC-MS as described above. From the methylated CHS reaction
products, a peak of m/z = 256 (Rt = 12.99 min) corresponding to di-
methylresveratrol was detected with mono- (m/z 286), di- (m/z 300)
and trimethylnaringenin (m/z 314). Likewise, a peak of m/z = 300
(Rt = 15.35 min) corresponding to dimethylnaringenin was detected
from the methylated STS reaction mixture together with di- (m/z
256) and trimethylresveratrol (m/z 270). For LC-MS analysis, Trx-
CHS (11 mg, 250 pkat) or Trx-STS (9.5 mg, 160 pkat) was incubated
with 0.1 mM p-coumaroyl-CoA and 0.3 mM malonyl-CoA in 50 ml of
0.1 M KPi bu¡er (pH 7.4) containing 1 mM DTT for 40 min at 37‡C.
At the end of incubation, the pH was raised to 9 with 1 N NaOH, and
the reaction mixture was further incubated at 37‡C for another 10 min
to complete chemical transformation of naringenin chalcone to nar-
ingenin [13]. The ethyl acetate extract was dried over Na2SO4 and the
solvent was removed under vacuum at 30‡C. The remaining products
were analyzed by LC-MS (Thermoquest LCQ) as previously described
[14].
Resveratrol: LC-APCIMS (positive), 229.1 [M+H], MS/MS (pre-
cursor ion at 229) m/z (rel. %) 211 (65), 135 (100), 119 (12), 107 (11).
Naringenin: LC-APCIMS (positive), 273.2 [M+H], MS/MS (precur-
sor ion at 273) m/z (rel. %) 171 (18), 153 (80), 147 (100).
3. Results
3.1. Sequence of A. hypogaea STS
When the deduced amino acid sequence of Japanese peanut
STS cloned in this study (Accession number: AB027606) was
compared to the published peanut STS sequence (Swiss-Prot
P20178) [10], 8 out of 389 amino acids were found to be
di¡erent. Those are Ser-46 corresponding to Gly-46 in Ref.
[10], Ser-195 to Ala-195, Ser-202 to Asn-202, Leu-236 to Ile-
236, Asp-281 to Gly-281, Pro-304 to Leu-304, Glu-315 to
Gln-315 and Ala-356 to Thr-356. This di¡erence in amino
acid sequence probably re£ects di¡erent origins of the plant
materials used.
3.2. Puri¢cation of CHS and STS
Puri¢cation of CHS and STS overexpressed in E. coli is
summarized in Table 1. Typical experiments yielded 0.3^0.4
Table 1











CHS Crude extract 29 36 1.2 (100) ^
DEAE ion exchange 4.5 9.1 2.0 25 1.7
Hydroxyapatite 1.7 6.5 3.8 18 3.2
Chromatofocusing 0.42 4.2 10 12 8.3
STS Crude extract 10 35 3.5 (100) ^
DEAE ion exchange 1.3 14 10 39 2.9
Hydroxyapatite 0.31 12 37 33 11
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mg of apparently homogeneous enzymes from 300 ml bacteria
culture (Fig. 2A). Recovery was 10^30% with about 10-fold
enrichment.
3.3. Identi¢cation of BNY and p-coumaroyltriacetic acid
lactone
Production of BNY and CTAL by STS as well as by CHS
was clearly visualized by TLC (Fig. 2B). The TLC spots were
identi¢ed with non-labeled carrier compounds (resveratrol
and naringenin) and with parallel experiment using p-coumar-
oyltriacetic acid synthase which has been recently cloned from
Hydrangea macrophylla and shown to produce CTAL and
BNY as the main product and a major byproduct, respectively
[14]. Further, the identity of BNY and CTAL was unambig-
uously determined by GC-MS and LC-MS. The production of
these derailment products by CHS and STS were dependent
on the presence of sulfhydryl reagents such as DTT in the
reaction mixture, consistent with the earlier report with
CHS [3]. It was thought that sulfhydryl reagent would act
as an acceptor to the enzyme-bound triketide (or tetraketide)
intermediate in a non-enzymatic trans-esteri¢cation to form
unstable thiol adduct, which should be immediately converted
to the corresponding pyrone [3]. In agreement with this no-
tion, DTT showed apparently parallel e¡ects on formation of
BNY and CTAL. However, the requirement of the sulfhydryl
reagent was not absolute, as these byproducts were still de-
tectable when the enzyme reaction was carried out in the
absence of DTT (data not shown). Acidi¢cation of the reac-
tion mixture to pH6 5 greatly enhanced the amounts of BNY
and CTAL detected on TLC. These results suggest that the
majority of these compounds, both being pyrone derivatives,
are present in the reaction mixture as free acids at neutral pH,
thus poorly extractable by ethyl acetate, and that lactoniza-
tion to form pyrone ring is non-enzymatic. Similar pH-de-
pendence of extraction of pyrone derivatives was also re-
ported recently by others [15]. Whereas CTAL was a major
byproduct of the CHS reaction, BNY was a major byproduct
of the STS reaction (Fig. 2B).
3.4. Cross-reaction
When the reaction products produced by puri¢ed recombi-
nant enzyme were analyzed by HPLC, a small radioactive
peak corresponding to resveratrol (Rt = 10 min) was detected
in the CHS products and a peak corresponding to naringenin
(Rt = 20 min) was detected in the STS products (Fig. 3).
Cross-reaction was veri¢ed by carrier dilution analysis. Suc-
cessive rounds of recrystallization of radioactive products in
the presence of non-labeled compounds gave crystals of con-
stant speci¢c radioactivity. For resveratrol produced by CHS,
the speci¢c radioactivity was 8200 dpm/mmol (methanol),
7300 (methanol), 7000 (ethyl acetate/hexane) and 6700 (ethyl
acetate/hexane), and for naringenin produced by STS, it was
8900 dpm/mmol (methanol), 7900 (methanol), 7500 (ethyl ace-
tate/hexane) and 8300 (ethyl acetate/hexane). The cross-reac-
tion was determined to be 2.7^4.2% (resveratrol/naringenin)
for CHS and 1.4^2.3% (naringenin/resveratrol) for STS. The
cross-reaction was further con¢rmed by GC-MS and LC-MS
analyses. The retention time, molecular mass and major
daughter ions in MS/MS were indistinguishable to those of
authentic compounds and those found in the literature [16].
Trx fusion enzymes were indistinguishable from the native
enzymes with regard to the pattern of byproduct production
and kinetic parameters (data not shown).
Fig. 1. Reaction steps catalyzed by CHS and STS and the products
produced in vitro.
Fig. 2. Puri¢cation and enzyme assay of P. lobata CHS and A. hy-
pogaea STS. A: SDS-PAGE was performed on a 12% acrylamide
minislab gel under reducing conditions. For both CHS and STS,
lane 1 contained 3 Wg of proteins obtained after (NH4)2SO4 frac-
tionation and lane 2 contained 1 Wg of puri¢ed enzyme. The pro-
teins were stained with Coomassie blue R250 (Bio-Rad). The num-
bers on left indicate molecular weight in kDa of the Mr marker
proteins. B: Radio thin layer chromatogram of enzyme assays using
puri¢ed recombinant CHS (5 Wg) and STS (2 Wg) and p-coumaroyl-
CoA and [2-14C]malonyl-CoA as substrates. The conditions for en-
zyme assay and TLC analysis are described in Section 2.
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4. Discussion
CHS puri¢ed from plants was shown to produce styrylpyr-
ones and other minor byproducts in certain in vitro conditions
[3,4]. In the present study, we showed that, like CHS, puri¢ed
recombinant peanut STS produced not only BNY, a styryl-
pyrone, but also CTAL, the recently found derailment prod-
uct at the stage of tetraketide intermediate [14]. This was not
unexpected since it has been thought that CHS and STS cata-
lyze identical condensation steps leading to the linear tetrake-
tide intermediate prior to di¡erent cyclization steps [1]. De-
tection of BNY and CTAL from the STS reaction products
provides an unequivocal evidence for this notion. Under the
conditions employed, CHS produces more byproducts than
STS (Figs. 2B and 3). This may re£ect the more loosely struc-
tured active site of CHS compared with that of STS, in vitro,
which allows to a greater extent premature thioester exchange
with sulfhydryl reagent present in the reaction mixture or
thioester hydrolysis by water to give derailment products.
CHS is believed to be present in the cell as a part of multi-
enzyme complex of £avonoid biosynthesis including polyke-
tide reductase, chalcone isomerase and other modifying en-
zymes to achieve ‘metabolite channeling’ [1,17].
Cyclization steps in CHS and STS are di¡erent; Dieckmann
condensation leading to naringenin chalcone in CHS and al-
dol condensation to stilbene in STS. Nonetheless, CHS and
STS produce counterpart products in low amounts (2^4% of
main products) which could not be detected by routine assays.
The possibility that the cross-reaction products were formed
during work-up by chemical transformation was thought to
be unlikely based on the following. First, although the corre-
sponding chemical transformations are known, they are nor-
mally carried out under harsh conditions unlike the work-up
procedures used in this study. For example, the Dieckmann
condensation of methyl ester of 7-phenyl-3,5,7-trioxohepta-
noic acid to corresponding acylphloroglucinol required a pro-
longed incubation under strongly basic conditions, such as
2 M KOH [18]. Even though aldol condensation of triketo
acids can proceed in weakly acidic (pH 5) aqueous bu¡er, the
products are fairly stable L-resorcylic acids [18]. Decarboxyl-
ation of aromatic carboxylic acids such as conversion of
6-styryl-L-resorcylic acid to pinosylvin and of orsellinic acid
to orcinol have been achieved either by heat (180‡C) [18,19],
by alcoholic KOH [20] or by a decarboxylase [21]. It should
be noted that stilbene carboxylic acids, though found in
nature [22], have not been detected from the STS reaction
mixture. Secondly, neither naringenin nor resveratrol was de-
tected after using an identical work-up procedure in the reac-
tion mixture produced by p-coumaroyltriacetic acid synthase
(CTAS), which catalyzes, like CHS and STS, three condensa-
tion reactions between p-coumaroyl-CoA and malonyl-CoA
to triketo acid but does not catalyze any cyclization reaction
[14]. This suggested that lactonization of the free triketo acid
predominates during work-up to give CTAL as a major by-
product (Fig. 1) and, therefore, we concluded that the cross-
reaction of CHS and STS was most likely enzymatic of na-
ture.
One reasonable interpretation for this seemingly unnatural
cross-reaction is that parts of heterologously overexpressed
enzymes are in unnatural conformational states and these
misfolded, yet soluble enzymes are responsible for the ob-
served cross-reaction. Overexpression in E. coli often leads
to misfolding especially for membrane-associated eukaryotic
proteins, as bacteria lack an intracellular membrane environ-
ment that may be necessary for e⁄cient and accurate folding
[23]. Both CHS and STS are shown to be weakly membrane-
associated in the plant cells [24,25] and CHS is associated with
other enzymes involved in the £avonoid biosynthesis pathway
[17]. However, an attempt to resolve conformational hetero-
geneity using hydroxyapatite chromatography was unsuccess-
ful, as cross-reaction activities were co-puri¢ed with the nat-
ural activities (data not shown). Another intriguing and
probably more conceivable possibility is that CHS and STS
possess intrinsic potential to catalyze cross-reaction possibly
due to conformational £exibility of their active sites, and that
this intrinsic, yet ‘cryptic’ capability of these enzymes to per-
form the cross-reaction was manifested under non-optimal
folding conditions during bacterial overexpression. Our recent
¢nding that cross-reaction of CHS and STS expressed in eu-
karyotic systems (yeasts and insect cells) apparently decreased
as compared to the cross-reaction found in this study with
bacterial expression system seems to support this idea (San-
kawa, unpublished data). In line with this idea, it should be
noted that cyclization steps in CHS and STS are proposed to
be under pure topological control [8]. Indeed, the recently
solved crystal structure of alfalfa (Medicago sativa) CHS by
Ferrer et al. did not reveal apparent functional amino acids in
the cyclization pocket that might participate in a speci¢c
Fig. 3. HPLC analysis of reaction products produced by puri¢ed re-
combinant P. lobata CHS (A) and A. hypogaea STS (B). Authentic
resveratrol and naringenin were added to the reaction products to
aid detection by UV absorbance (thin line) and the resulting sample
was injected onto a TOSOH ODS80-Ts column. The products were
separated with an isocratic elution of 50% aqueous methanol con-
taining 1% acetic acid. Radioactivity (thick line) of each fraction
(0.5 ml) was measured and fractions corresponding to the cross-re-
action products (resveratrol for CHS and naringenin for STS) were
pooled and used for carrier dilution analysis.
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CHS-type cyclization reaction [26]. The authors, therefore,
proposed that alterations in the surface topology of the cyc-
lization pockets of CHS and STS may a¡ect the stereochem-
istry of the cyclization reactions.
Based on phylogenetic analysis, Schro«der et al. [2] proposed
di¡erent STSs evolved from CHSs independently several times
by a limited number of amino acid exchanges. However, con-
sensus (signature) amino acid sequences characteristic to CHS
or to STS have yet to be recognized. It may result from the
insu⁄cient number of STS sequences available (6 entries in
Swiss-Prot). On the other hand, STS conceivably gained its
new activity by changing active site geometry rather than by
introducing a few new functional amino acids in the active site
of STS. A closely related case can be found in chemical diver-
sity of higher plant fatty acids, where independent, multiple
evolution of oleate 12-hydroxylase from oleate 12-desaturase
was proposed. Site-directed mutagenesis studies involving as
few as seven amino acids suggested that catalytic plasticity in
these two enzymes is achieved by changing active site geom-
etry leading to di¡erent partitioning of a common intermedi-
ate into di¡erent reaction products [27]. Clearly, further stud-
ies with regard to the origin of the cross-reaction of CHS and
STS overexpressed in E. coli are warranted.
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